254 related articles for article (PubMed ID: 30393127)
1. Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues.
Kunihiro AG; Brickey JA; Frye JB; Luis PB; Schneider C; Funk JL
J Nutr Biochem; 2019 Jan; 63():150-156. PubMed ID: 30393127
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Inhibition of TGFβ signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites.
Kunihiro AG; Brickey JA; Frye JB; Cheng JN; Luis PB; Schneider C; Funk JL
J Nutr Biochem; 2022 Jan; 99():108842. PubMed ID: 34407450
[TBL] [Abstract][Full Text] [Related]
3. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.
Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316
[TBL] [Abstract][Full Text] [Related]
4. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis.
Wright LE; Frye JB; Lukefahr AL; Timmermann BN; Mohammad KS; Guise TA; Funk JL
J Nat Prod; 2013 Mar; 76(3):316-21. PubMed ID: 23145932
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of osteolytic bone metastases.
Guise TA
Cancer; 2000 Jun; 88(12 Suppl):2892-8. PubMed ID: 10898330
[TBL] [Abstract][Full Text] [Related]
6. Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice.
Cheng JN; Frye JB; Whitman SA; Ehsani S; Ali S; Funk JL
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38715255
[TBL] [Abstract][Full Text] [Related]
7. TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.
Gupta J; Robbins J; Jilling T; Seth P
Cancer Biol Ther; 2011 Feb; 11(3):311-6. PubMed ID: 21099351
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.
Kakonen SM; Selander KS; Chirgwin JM; Yin JJ; Burns S; Rankin WA; Grubbs BG; Dallas M; Cui Y; Guise TA
J Biol Chem; 2002 Jul; 277(27):24571-8. PubMed ID: 11964407
[TBL] [Abstract][Full Text] [Related]
9. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA
J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131
[TBL] [Abstract][Full Text] [Related]
14. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
16. Beta-Glucuronidase Catalyzes Deconjugation and Activation of Curcumin-Glucuronide in Bone.
Kunihiro AG; Luis PB; Brickey JA; Frye JB; Chow HS; Schneider C; Funk JL
J Nat Prod; 2019 Mar; 82(3):500-509. PubMed ID: 30794412
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
18. Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer.
Wright LE; Frye JB; Gorti B; Timmermann BN; Funk JL
Curr Pharm Des; 2013; 19(34):6218-25. PubMed ID: 23448448
[TBL] [Abstract][Full Text] [Related]
19. Bone-Specific Metabolism of Dietary Polyphenols in Resorptive Bone Diseases.
Kunihiro AG; Luis PB; Frye JB; Chew W; Chow HH; Schneider C; Funk JL
Mol Nutr Food Res; 2020 Jul; 64(14):e2000072. PubMed ID: 32506808
[TBL] [Abstract][Full Text] [Related]
20. Pro-metastasis function of TGFbeta mediated by the Smad pathway.
Kang Y
J Cell Biochem; 2006 Aug; 98(6):1380-90. PubMed ID: 16598746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
